Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: November 2023

MissionIRNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) News of FDA Type-B Meeting Shared in Syndicated Audio Broadcast

Posted on November 17, 2023 by MissionIR

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, is spotlighted in a recent NetworkNewsAudio broadcast. According to the broadcast, the company recently announced that it had met with the U.S. Food and Drug Administration (“FDA”) … Continue reading →

Posted in PaxMedica Inc. PXMD | Leave a comment

D-Wave Quantum Inc. (NYSE: QBTS) Announces European Office, Signs Two-Year Contract Extension with QuantumBasel

Posted on November 17, 2023 by MissionIR

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, and QuantumBasel, Switzerland’s quantum innovation hub, recently announced a two-year extension to the strategic agreement between the companies … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Partner Receives Key Retail License, Begins Shipping EVs

Posted on November 16, 2023 by MissionIR

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, announced that its partner, the Randy Marion Automotive Group (“RMA”), has received its North Carolina license to retail Mullen’s commercial EVs. According to the announcement, this is a required dealer … Continue reading →

Posted in Mullen Automotive Inc. MULN | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Release Interim Data by Year End for Lead Treatment Candidate Berubicin

Posted on November 16, 2023 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company focused on developing innovative therapies for central nervous system disorders, specifically aggressive brain cancers. The company today announced its confidence in sharing the results from an interim analysis on one of its … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

MissionIRNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Releases Q3 2023 Financial Report, Corporate Update

Posted on November 16, 2023 by MissionIR

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, is reporting on its financial results as well as providing a comprehensive business update for the third quarter ended Sept. 30, 2023. Highlights of the report include … Continue reading →

Posted in PaxMedica Inc. PXMD | Leave a comment

Diamond Lake Minerals Inc. (DLMI) Building Value for Investors with Focus on STO Frontier, Other Digital Assets

Posted on November 16, 2023 by MissionIR

Earlier this year, one of South Korea’s biggest commercial banks — NongHyup — established a security token-centered ecosystem that has produced a consortium joined by other large banks in the country (https://ibn.fm/rsKhn). This month, brokerage firm Cathay Securities announced it … Continue reading →

Posted in Diamond Lake Minerals Inc. DLMI | Leave a comment

Freight Technologies Inc. (NASDAQ: FRGT) CEO Underscores Commitment to Continued Growth in Letter to Shareholders

Posted on November 16, 2023 by MissionIR

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a technology company whose lead product is Fr8App, an industry-leading freight-matching platform powered by artificial intelligence (“AI”) and machine learning, is making substantial strides in the realization of its objectives. In a letter to shareholders, … Continue reading →

Posted in Freight Technologies Inc. FRGT | Leave a comment

Clene Inc. (NASDAQ: CLNN) Reports Q3 2023 Financial Results, Recent Operating Highlights for Its ALS Clinical Program

Posted on November 16, 2023 by MissionIR

Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of a pipeline of novel clean-surfaced nanotechnology therapeutics for the treatment of central nervous system disorders, including Amyotrophic … Continue reading →

Posted in Clene Inc. CLNN | Leave a comment

MissionIRNewsBreaks – NextPlat Corp.’s (NASDAQ: NXPL) Strong Growth Featured in Proactive Podcast

Posted on November 15, 2023 by MissionIR

NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, was featured in an interview with Proactive, where its CEO Charlie Fernandez joined host Steve Darling to provide an update on the company’s latest financial results. NextPlat has made impressive strides in … Continue reading →

Posted in NextPlat Corp. NXPL | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Continues to Advance Patented DehydraTECH(TM)

Posted on November 15, 2023 by MissionIR

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is steadily advancing its patented DehydraTECH(TM) technology for a growing range of applications including oral nicotine, hypertension, antivirals, human hormone therapy, diabetes and more. Through previous clinical trials, … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment